Rationale and design of the PHOspholamban RElated CArdiomyopathy intervention STudy (i-PHORECAST)

BACKGROUND: The p.Arg14del (c.40_42delAGA) phospholamban (PLN) pathogenic variant is a founder mutation that causes dilated cardiomyopathy (DCM) and arrhythmogenic cardiomyopathy (ACM). Carriers are at increased risk of malignant ventricular arrhythmias and heart failure, which has been ascribed to...

Descripción completa

Detalles Bibliográficos
Autores principales: te Rijdt, W. P., Hoorntje, E. T., de Brouwer, R., Oomen, A., Amin, A., van der Heijden, J. F., Karper, J. C., Westenbrink, B. D., Silljé, H. H. W., te Riele, A. S. J. M., Wiesfeld, A. C. P., van Gelder, I. C., Willems, T. P., van der Zwaag, P. A., van Tintelen, J. P., Hillege, J. H., Tan, H. L., van Veldhuisen, D. J., Asselbergs, F. W., de Boer, R. A., Wilde, A. A. M., van den Berg, M. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bohn Stafleu van Loghum 2021
Materias:
Original Article – Study Design Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799798/
https://www.ncbi.nlm.nih.gov/pubmed/34143416
http://dx.doi.org/10.1007/s12471-021-01584-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799798/
https://www.ncbi.nlm.nih.gov/pubmed/34143416
http://dx.doi.org/10.1007/s12471-021-01584-5

Ejemplares similares